Juan Antonio
González Díaz
Publications (35) Publications de Juan Antonio González Díaz
2020
-
Design and implementation of a teaching project for the formation of medical identity in medical students
Educacion Medica, Vol. 21, Núm. 3, pp. 207-211
2016
-
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer
British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663
2014
-
Gobierno y organización en la Universidad: relaciones entre autoridad y poder
Revista empresa y humanismo, Vol. 17, Núm. 2, pp. 61-74
2012
-
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial
International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593
2011
-
Cáncer de páncreas
Guías clínicas en oncología radioterápica: tumores digestivos (Arán), pp. 65-81
-
Guías clínicas en oncología radioterápica: tumores digestivos
coord.
Arán
-
Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy
Journal of Surgical Oncology, Vol. 104, Núm. 2, pp. 124-129
-
Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: Is there still a place for ecoendoscopic ultrasound?
International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 2, pp. 439-444
-
Patterns of response after preoperative treatment in gastric cancer
International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704
-
Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach
Clinical and Translational Oncology, Vol. 13, Núm. 12, pp. 899-903
2010
-
Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
BMC Cancer, Vol. 10
-
Moving towards a more comprehensive vision of GI cancer
Clinical and Translational Oncology
-
Updating controversies on the multidisciplinary management of gastric cancer
Clinical and Translational Oncology, Vol. 12, Núm. 10, pp. 677-685
2009
-
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer
British Journal of Cancer, Vol. 100, Núm. 6, pp. 932-940
-
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells
Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290
2008
-
Evaluating response with endoscopic ultrasound (EUS) after preoperative chemoradiation (CHRT) in gastric cancer
Journal of Clinical Oncology
-
Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755
-
cT3N0 rectal cancer: Potential overtreatment with preoperative chemoradiotherapy is warranted
Journal of Clinical Oncology, Vol. 26, Núm. 3, pp. 368-373
2007
-
Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy
Annals of Surgical Oncology, Vol. 14, Núm. 5, pp. 1744-1751
-
Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole
Cancer Biology and Therapy, Vol. 6, Núm. 1, pp. 70-75